Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure

NCT02352285 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Hyponatremia

Interventions

DRUG: Tolvaptan
DRUG: Placebo

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.